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In the present study, we established an animal model for dengue virus infection using severe combined immunodeficient
mice transplanted with a human hepatocarcinoma cell line (HepG2). At 7–8 weeks after transplantation, the HepG2-grafted
mice were infected intraperitoneally with dengue virus type 2 (DEN-2). A higher titer of the virus was detected in the liver and
serum but not in the brain in the early stage of postinfection. When the mice showed paralysis, the highest titer of virus was
detected in the serum and brain. DEN-2 antigens were also found in HepG2 cells of the liver in the early stage and some
neurons of the brain in the late stage. Upon clinical examination, thrombocytopenia, prolonged partial thromboplastin time,
and increased hematocrit, blood urea nitrogen, and tumor necrosis factor a were seen in the paralyzed mice. Moreover, mild
hemorrhage in the liver and tarry stool in the small intestine were observed in some mice. Our results show some similarities
to human DEN infection and this mouse model might be valuable for studying some aspects of pathogenesis of this disease.
© 1999 Academic Press
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Dengue (DEN) viruses are mosquito-borne RNA vi-
uses that are classified serologically into four anti-
enically distinct types (DEN-1, 2, 3, 4). They infect
illions of people in tropical and subtropical regions
f the world and can cause a mild to debilitating febrile
llness (classical dengue fever, DF) or life-threatening
yndrome (dengue hemorrhagic fever/dengue shock
yndrome, DHF/DSS). However, the pathogenesis of
uman dengue infection remains unknown and no
uccessful vaccine is available as yet (Eckels, 1993). A
ajor difficulty in studying dengue infection and de-
eloping a dengue virus vaccine is the absence of a
uitable animal model (Bhamarapravati, 1993). Exper-
mental infection of rhesus monkeys results only in
ow-titer viremia of short duration (Innis et al., 1988).
he availability of monkeys for experimentation is very
carce due to wildlife conservation policies. Severe
ombined immunodeficient (SCID) mice do not pro-
uce functional T and B cells and lack detectable
mmunoglobulin (Bosma et al., 1983). SCID mice re-
onstituted with human peripheral blood lymphocytes
nd infected with DEN-1 virus were first used to de-
elop an animal model (Wu et al., 1995). However, only
ome of these mice showed sensitivity to DEN-1 in-
ection.
In the past few years, unusual clinical manifestations,
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70ostly cerebral and hepatic symptoms, have become
ore common in patients with DEN virus infection (Ra-
ajee and Mukundan, 1994; Thisyakorn and Thisyakorn,
994). Although the liver is not a major target organ, the
nvolvement of liver cells in pathogenesis of DEN virus
nfection has been indicated by the abnormal liver func-
ion, pathological findings, and detection of viral antigen
n hepatocytes and Kupffer’s cells at biopsies (Bhamara-
ravati et al., 1967; Burke, 1968; Rosen et al., 1989; Kuo et
l., 1992). It was reported recently that DEN virus can
eplicate in a human hepatocarcinoma cell line, HepG2,
nd infectious particles are released into the culture
edium (Marianneau et al., 1996; 1997). We have trans-
lanted HepG2 cells into SCID mice to develop an ani-
al model for studying the pathogenesis of DEN virus
nfection.
RESULTS
erum hALB levels and replication of HepG2 cells
n host mice
The transplanted HepG2 cells grew in the grafted
ice. Serum hALB, which is released from transplanted
epG2 cells, could not be detected in host mice until 14
ays after transplantation. The level then increased and
eaked at day 60 followed by a gradual decrease (Fig. 1).
n gross and microscopic observations, proliferating
epG2 cells were usually distributed in the liver (arrows
n Fig. 2) and less frequently in the spleen. However,
epG2 cells were not observed in the lung, small intes-ine, or brain. These findings show that HepG2 cells
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71MOUSE MODEL FOR DENGUE VIRUS INFECTIONnjected through the spleen translocated into the liver of
ost mice and propagated there. The rate of successful
ransplantation was about 90% in HepG2-inoculated
ice (n 5 20) and the mice were healthy and survived
ore than 12 weeks after transplantation.
EN-2 virus infection of HepG2-grafted mice;
linical signs
After intraperitoneal (ip) infection with DEN-2 virus, the
epG2-grafted SCID mice gradually developed anorexia,
sthenia, and decreased body weight. At day 13 to 18
ostinfection (p.i.), all of these mice showed hind-leg
aralysis and lower body temperature. Biopsies showed
hat the liver usually shrank or occasionally became
lightly enlarged, and most of the HepG2 cells were
estroyed by DEN virus indicated by gross or histologi-
al view of livers in which HepG2 cell masses disap-
eared. Small quantities of ascites were observed in
bout 25% of the infected HepG2-grafted mice at day
1 p.i. and the day of paralysis onset. Tarry stool in the
mall intestine was sometimes seen in the infected,
rafted mice but not in the control mice. Most of the
nfected, grafted mice (about 85%) died 6–12 h after onset
f paralysis.
Clinical parameters of the HepG2-grafted mice with ip
nfection are summarized in Table 1. PC gradually de-
reased from day 5 p.i. and was significantly lower than
hat of uninfected HepG2-grafted mice at day 8 p.i. (P ,
.05). The lowest platelet count (PC) (40 3 104 platelets/
m3) was seen at day 13–18 p.i. (paralysis onset; DP in
able 1), and it was significantly different from those of
ays 5, 8, and 11 p.i. and the control group (P , 0.01).
artial thromboplastin time (PTT) was prolonged and
ematocrit (Ht) was increased in all of the paralyzed
ice. Serum tumor necrosis factor a (TNF a) and blood
rea nitrogen (BUN) did not change during the early
tage of DEN-2 virus infection, but both dramatically
FIG. 1. Level of human albumin in the serum of SCID mice after
ransplantation of HepG2 cells. Values represent mean 6 SD, n 5 5
nimals. **P , 0.01 vs before HepG2 cell transplantation.ncreased in all of these mice at the onset of paralysis tDP, in Table 1). At that time, TNF a and BUN values were
18 pg/ml and 33 mg/dl, respectively, which were signif-
cantly higher than those of the control group (P , 0.01).
In contrast to infected, HepG2-grafted SCID mice, an-
rexia, asthenia, and decreased body weight were not
een in uninfected, HepG2-grafted SCID mice. Clinical
arameters of PC, PTT, TNF a, and BUN in these mice
ere 80.39 3 104 platelets/mm3, 10 s, 45.00 pg/ml, and
6.80 mg/dl, respectively. Compared with ungrafted mice
ithout infection, they did not show any changes except
or slightly increased Ht (Tables 1 and 2). Biopsy showed
nly replicating HepG2 cell masses in the liver of these
ice and no ascites were seen. In the ip-infected, un-
rafted SCID mice, although 15% of these mice (n 5 20)
ad hind-leg paralysis 35–60 days p.i., neither abnormal-
ties in gross and histological examinations of several
rgans (liver, lung, spleen, and small intestine) nor
hanges of PC, PTT, Ht, serum TNF a, and BUN were
bserved.
istribution of DEN-2 virus in HepG2-grafted mice
Virus titers in the serum and several organs at different
imes after ip DEN-2 virus infection are shown in Fig. 3.
irus was detected in the livers of all of the infected,
epG2-grafted mice. Virus titer was 104.1 PFU/g at day
p.i. and peaked at day 8 at about 104.9 PFU/g. At day 11
nd the day of paralysis onset (13–18 days p.i.), titers
ecreased, and virus was detected in only 60 and 40% of
nfected mice, respectively.
Viremia was detected in 60% of the mice at day 5 p.i.
nd in 80% of the mice at the day 8 p.i. with titers of
03.2–106.0 PFU/ml. From day 11 p.i. to the onset of paral-
sis, viremia at 103.8–105.7 PFU/ml was detected in all of
he infected, HepG2-grafted mice. Virus was not de-
ected in the brain until day 11 p.i., when virus was
easured at 103.3–105.6 PFU/g in 80% of the mice (Fig. 3).
igh virus titers of 105.6–106.6 PFU/g were seen in all of
hese mice on the day of paralysis onset. Virus was not
etectable in other organs, including spleen, lung, and
mall intestine throughout the course of disease. More-
ver, when ungrafted SCID mice were inoculated ip with
EN-2 virus, there was no detectable virus in the serum
r liver. However, virus (103.0 PFU/g) was detected in the
rain of 15% these mice 35–60 days p.i.
istopathological and immunohistochemical
bservations of DEN-2 virus-infected,
epG2-grafted mice
In hematoxylin and eosin (HE) staining of liver sections
f DEN-2 virus-infected, HepG2-grafted mice, mild hem-
rrhage, congestion, and edema were seen in mice liver
ell masses of some lobules and HepG2 cell masses
Fig. 4a). Hepatocyte swelling, cytoplasmic vacuolation,
nd hypertrophy of Kupffer’s cells were also observed inhe livers of the mice. In the small intestine, mucosal
c
s
o
(
s
H
m
H
t
h
g
H
m
f
s
a
v
N
e
a
(
c
o
w
5
w
( urons.
72 AN ET AL.ongestion, small quantities of fresh blood in the muco-
ae (Fig. 4b), and macrophage infiltration into the lumen
f the intestine were observed in some paralyzed mice
Figs. 4c and 4d). No histopathological changes were
een in the liver and small intestine of control uninfected,
epG2-grafted mice or control virus-infected, ungrafted
ice.
To determine whether DEN-2 virus replicated in the
epG2 cells or normal mouse hepatocytes, liver sec-
FIG. 2. Replication of HepG2 cells (arrows) in the SCID mouse liver a
osin staining, 3100.
FIG. 4. Histopathological observation of organs from HepG2-grafted
fter infection had hemorrhage (H), congestion, and edema (E) in host li
arrows) in the mucosae of the small intestine at the day of paralysis on
ells, 3400. (c) Macrophage infiltration (arrows) in the lumen of the sma
f the macrophages, 3300.
FIG. 5. Double-staining of liver sections to identify the site of DEN-2
as stained with anti-human albumin (a marker for HepG2 cells) antibo
04 and 301) (Kimura-Kuroda and Yasui, 1986). DEN virus antigens we
FIG. 6. Double-staining of brain sections to identify the site of DEN-2
as stained with anti-microtubule-associated protein 2 (a marker for
Kimura-Kuroda and Yasui, 1986). DEN virus antigens were seen in neions were stained for both DEN viral antigens and suman albumin (hALB) by double staining. Viral anti-
ens were detected in most of the hALB-positive
epG2 cells but not in the hepatocytes of the host
ouse (Figs. 5a and 5b). Moreover, viral antigens were
requently observed in the neurons when the brain
ections were double-stained with anti-microtubule-
ssociated protein 2 (anti-MAP2) antibodies and anti-
iral monoclonal antibodies 301/504 (Figs. 6a and 6b).
o detectable viral antigens were seen in the lung,
0 after transplantation. (a) Gross examination, 33; (b) hematoxylin and
ouse inoculated ip with DEN-2 virus. (a) Section of the liver at day 11
ls of some lobules. HE staining, 3150. (b) Small quantity of fresh blood
staining, 3200. (Inset) A higher magnification showing the red blood
ine of a paralyzed mouse, HE staining, 3100. (d) A higher magnification
plication in infected, HepG2-grafted SCID mice. (a) Section of the liver
nd (b) stained with anti-DEN monoclonal antibodies (a mixture of MAb
in HepG2 cells, 3350.
plication in infected, HepG2-grafted SCID mice. (a) Section of the brain
ns) antibodies and (b) stained with anti-DEN monoclonal antibodies
3350.t day 6
SCID m
ver cel
set. HE
ll intest
virus re
dies a
re seen
virus re
neuropleen, and small intestine.
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73MOUSE MODEL FOR DENGUE VIRUS INFECTIONomparison of clinical parameters and virus titers
etween HepG2-grafted SCID mice infected ip and
ngrafted, SCID mice infected intracerebrally (IC)
Ungrafted SCID mice infected ic with DEN-2 virus also
howed hind-leg paralysis at day 12 p.i. and then died at
ay 13 or 14 p.i., although biopsy showed no significant
bnormal findings. These mice were examined for the
evels of PC, PTT, Ht, TNF a, and BUN and the data were
ompared with those of the HepG2-grafted mice infected
p (Table 2). On the day of paralysis onset, the ic group
howed no abnormal changes in PTT, Ht, TNF a, and
UN and only slightly decreased PC. In contrast, the ip
roup showed drastically decreased PC, prolonged PTT,
nd increased Ht, TNF a, and BUN. The difference be-
ween two groups for each parameter was significantly
P , 0.01).
Virus distributions in the mice of both groups were
lso compared (Table 2). Although equivalent virus titers,
05.7 PFU/g, were detected in the brains of both groups,
nly a few mice in the ic group had a low titer of virus in
he serum, and no virus was detected in the liver of these
ice. On the other hand, virus was usually detected in
T
Changes of Platelet Count (PC), Partial Thromplastin Time (PTT), H
Nitrogen (BUN) after Intraperitoneal Infection
Days p.i. PC (3104/ml) PTT (s)
5 70.28 6 11.43 11.00 6 1.0
8 63.82 6 8.48* 11.40 6 1.29
11 48.53 6 17.86** 11.30 6 0.45
DPa 40.30 6 15.34** 29.35 6 11.98**
Contb 80.39 6 11.92 10.21 6 1.10
Note. Each average value is from seven mice.
a DP, day of paralysis onset (range 13–18 days postinfection).
b Cont, control group (HepG2-grafted mice without infection).
* P , 0.05 vs Cont.
** P , 0.01 vs Cont.
T
Comparison of Virus Titer and Clinical
ic infection
ungrafted mice
Virus titer (log PFU/g)
Serum 1.280 6 1.420
Brain 5.732 6 0.256
Liver ND
PC (3104/ml) 55.61 6 15.58
PTT (s) 12.63 6 1.11
TNF a (pg/ml) 12.50 6 25.00
BUN (mg/dl) 17.13 6 3.87
Ht (%) 40.57 6 2.53
Note. ND, not detectable. Each average value is from seven mice k
** P , 0.01 vs ic infection.he serum (average of 104.7 PFU/ml) and liver (103.9 PFU/g)
f all of the HepG2-grafted mice in the ip group (P , 0.01
or the serum).
DISCUSSION
epG2-grafted SCID mice had a high sensitivity
o DEN virus infection
To develop a useful animal model for DEN virus infec-
ion, HepG2 cells, which support DEN viral replication
Marianneau et al., 1996, 1997), were transplanted into
CID mice. Replication of HepG2 cells in the host mice
as confirmed by an increase of serum hALB and prop-
gation of HepG2 cells in the liver. These results indi-
ated that HepG2 cells injected into the spleen migrated
o the liver and grew there. The successful transplanta-
ion rate via the spleen was more than 90% and was
igher than other transplantation routes (about 40% suc-
ess), such as intraperitoneal injection or direct injection
nto the liver (data not shown).
All of these virus-infected mice showed gradual illness
nding in paralysis and cachexy, and finally death. From
rit (Ht), Serum Tumor Necrosis Factor a (TNF a), and Blood Urea
G2-Grafted Mice with Dengue Type 2 Virus
Ht (%) TNF a (pg/ml) BUN (mg/dl)
50 6 4.51 22.10 6 49.19 17.31 6 1.35
00 6 3.54 55.00 6 51.71 19.58 6 2.85
.60 6 2.07 61.00 6 42.18 17.40 6 3.37
20 6 1.64** 718.33 6 215.17** 33.31 6 14.09**
80 6 2.59 45.00 6 44.72 16.80 6 1.86
eters between Mice Infected ic or ip
ip infection HepG2-
grafted mice
Ungrafted mice
without infection
4.656 6 0.687**
5.666 6 0.417
3.941 6 0.334
40.30 6 15.34** 77.59 6 15.31
29.35 6 11.18** 11.43 6 1.21
718.33 6 215.17** 10.32 6 23.40
33.31 6 14.09** 20.32 6 4.34
55.20 6 1.64** 38.94 6 2.31
the day of paralysis onset.ABLE 1
ematoc
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74 AN ET AL.ay 5 to the day of paralysis onset, the frequency of
iremia increased from 60 to 100%, and the virus titers
ncreased. In contrast, when ungrafted SCID mice were
noculated ip with DEN-2 virus, neither detectable vire-
ia nor significant clinical manifestations were observed
n most of mice. These results indicated that HepG2-
rafted SCID mice had a higher sensitivity to DEN virus
nfection, and the transplantation of HepG2 cells was
mportant in achieving this high sensitivity.
It is interesting that higher titers of virus were seen in
he livers of all mice at the early stage p.i., but the titers
ecreased gradually. This might have resulted from ex-
austion of HepG2 cells due to viral replication. On the
ther hand, both frequency and titer of viremia were low
t the early stage, but increased gradually and reached
he highest level at the day of paralysis onset. Virus titer
n the brain also increased from day 11 to the day of
aralysis onset. These results strongly suggested that
EN-2 virus replicated in the liver at first and then dis-
eminated to the brain through the bloodstream, show-
ng a disease course somewhat similar to that of human
EN virus infection in which virus first replicated in local
issue after infection and then was carried via the blood-
tream into brain (Lum et al., 1996; Nimmannitya et al.,
987).
Target cells and organs for DEN virus replication in
umans remain unclear. Mononuclear phagocytes have
een considered as only one site of virus replication in
umans (Halstead, 1981). In the present study, high virus
iter and viral antigens were detected in the transplanted
epG2 cells in the liver. This is consistent with results
rom Rosen et al. (1989), who reported that recovery of
he virus from the liver was very common in human DEN
FIG. 3. Distribution of DEN-2 virus in the serum and several organs o
iter was determined by plaque assay on a Vero cell monolayer culturirus infection. High virus titer and viral antigens were blso observed in the brain of infected mice. Those re-
ults indicated that HepG2 cells and neurons are main
ites of viral replication of these mice. Recently, we found
hat DEN virus replicated in neurons of the anterior horn
f the lumbar spinal cords in paralyzed mice (unpub-
ished data), which might partially explain the occurrence
f hind-leg paralysis.
HF/DSS-like manifestations were observed
n our model mice
It has been reported that thrombocytopenia and pro-
onged PTT are common in a severe form of human DEN
irus infection. PTT and PC are usually used as potential
ndices for predicting DHF (Chua et al., 1993; Hathirat et
l., 1993; Garcia et al., 1995). In this study, the infected,
epG2-grafted SCID mice showed gradual decreases in
C and prolonged PTT. Moreover, mild hemorrhage in
he liver and small intestine was also seen. In human
HF, gastrointestinal bleeding and small focal hemor-
hages in the liver are very common (Burke, 1968; Rosen
t al., 1989; Rajajee and Mukundan, 1994). It seems that
he mice showed some DHF-like manifestations.
BUN is a final metabolic product of protein and is
liminated from the kidney. In general, an elevated BUN
evel suggested renal dysfunction, hemoconcentration,
r gastrointestinal bleeding. In the present study, in-
reased Ht and BUN were seen in the paralyzed mice
nd small quantities of ascites were seen in some mice,
ndicating that the infected mice had some degree of
emoconcentration and renal dysfunction. It is probable
hat these resulted from increased vascular permeability
nd extravasation of fluid into interstitial spaces. It might
2-grafted SCID mice infected intraperitoneally with DEN-2 virus. Virus
point represents one sample from one mouse.f HepGe inferred that the mice showed evidence of shock.
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75MOUSE MODEL FOR DENGUE VIRUS INFECTIONHowever, some disease presentations in infected,
epG2-grafted SCID mice were different from that of
uman DEN infection. For example, viremia is usually no
onger detectable at the time of onset of DHF/DSS in
umans (Vaughn et al., 1997), whereas DHF/DSS-like
anifestations were seen at the late stage when viremia
howed high titer in this animal model. It may be related
o the fact that SCID mice do not produce specific anti-
odies to neutralize the virus. The differences might
ake some limitations of use of this animal model to
xtrapolate the situation in humans. Nevertheless, the
nimal model was considered to be helpful for studying
ome aspects of human DEN infection.
Although the mechanism of hemorrhage in DHF is
nclear, decreased PC is considered to play a major role
Isarangkura and Tuchinda, 1993). The pathogenesis of
hrombocytopenia is poorly understood. La Russa and
nnis (1995) suggested that DEN virus-induced bone
arrow suppression resulted in thrombocytopenia
hrough depressed platelet synthesis in human DHF.
ang et al. (1995) proposed the possibility that binding of
EN virus to platelets might be involved in the thrombo-
ytopenia in DHF. In the present study, in addition to
hrombocytopenia, prolonged PTT was seen. The find-
ngs indicate that not only thrombocytopenia, but also
onsumptive coagulopathy played a critical role in the
leeding tendency in the mice. Further studies are
eeded to clarify the underlying mechanism of hemor-
hage in human DEN infection.
TNF a might be involved in the etiology of shock in
HF/DSS, since TNF a is a strong inflammatory mediator
nd is released from macrophages activated by acute
iral infection, endotoxin, or phagocytosis. In the present
tudy, the infected mice showed increased TNF a in the
erum and macrophage infiltration into the lumen of the
mall intestine as well as hypertrophy of Kupffer’s cells in
he liver. Macrophages activated by DEN-2 virus infec-
ion might be an important source of TNF a. Dysfunction
r destruction of vascular endothelial cells by TNF a
ould cause increased vascular permeability leading to
ome degree of shock (Kurane and Ennis, 1994, 1997).
ecently, significant elevation in serum TNF a has been
eported in patients with DHF/DSS, and a close relation-
hip between sequential changes in serum TNF a level
nd clinical progression of the disease has been shown
Yadav et al., 1991; Iyngkaran et al., 1995). Exposure of
ascular endothelial cells to TNF a dramatically in-
reased adhesive interaction of the cells with neutrophils
n vitro (Anderson et al., 1997). It is likely that TNF a
articipated in the etiology of some DHF/DSS-like man-
festations observed in the mice in this study.
Finally, the above-described various DHF/DSS-like
anifestations in HepG2-grafted mice infected ip with
EN-2 virus are not directly associated with viral repli-
ation in the brain, because ungrafted-SCID mice in-ected ic showed none of these DHF/DSS-like findings, plthough the latter mice showed hind-leg paralysis and
iral replication in the brain. Our mouse model has sev-
ral clinical, hematological, histopathological, and viro-
ogical similarities to human DEN infection. This appears
o be a valuable mouse model for studying some aspects
f pathogenesis of the disease.
MATERIALS AND METHODS
ice
Female SCID (C.B.-17/Icr Tac-scid) mice were pur-
hased from Clea Co. (Tokyo, Japan). They were main-
ained in sterile cages in a specific pathogen-free room
nd were given sterile water and food.
ransplantation
HepG2 cells were cultured in Dulbecco’s modified
agle’s medium with 10% fetal bovine serum (FBS), 4 mM
lutamine, penicillin, and streptomycin at 37°C. The cells
ere dissociated with 0.25% trypsin and then suspended
t 1.5 3 108 cells/ml in Haemaccel (Hoechst-Russel
harmaceuticals) containing 50% FBS. These HepG2
ells were injected in a volume of 60–70 ml (about 1 3
07 cells) with a 26-gauge needle into the spleen of each
ther-anesthetized SCID mouse aged 8 weeks. To con-
irm successful transplantation, the concentration of
ALB in the serum was determined by an enzyme-linked
mmunosorbent assay (ELISA), and the liver and spleen
ere taken for histological observation at time intervals
fter transplantation.
irus inoculum
DEN-2 (strain Tr1751) virus, which was isolated from a
atient with DF and kindly provided by Dr. Ohtani A
National Institute of Infectious Diseases, Japan), was
ropagated in Aedes albopictus mosquito (C6/36) cells
Igarashi, 1978) and stored at 280°C until use. The titer
f virus stock was adjusted to 2 3 106 PFU/ml.
irus infection
The design of the experiment is shown in Table 3.
epG2-grafted SCID mice were infected ip with 106 PFU/
ouse of DEN-2 virus at 7–8 weeks after transplantation.
s controls, the following three experimental groups
ere prepared: HepG2-grafted SCID mice aged 15–16
eeks, without infection; ungrafted SCID mice aged 16
eeks, ip infection with 106 PFU/mouse of DEN-2 virus;
ngrafted SCID mice aged 16 weeks, intracerebral inoc-
lation with 106 PFU/mouse of DEN-2 virus.
linical parameters
The infected mice were observed daily for signs of
orbidity, especially visible hemorrhage, tarry stool, andaralysis. Rectal body temperature was measured. Un-
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76 AN ET AL.er ether anesthesia, samples of blood were obtained
rom the heart and/or vascular plexus of brachium at
ays 5, 8, and 11 p.i. and at the day of paralysis onset.
amples of brain, liver, spleen, lung, and small intestine
ere taken at the same time. The blood sample was
sed for clinical examinations and virus titration as fol-
ows: (1) platelet count and hematocrit; (2) partial throm-
oplastin time was assayed using a thromboplastin test
it (Wako); (3) serum blood urea nitrogen was measured
sing a B-test kit (urease-indophenol method, Wako); (4)
he concentration of TNF a in the serum was determined
y ELISA using a mouse TNF a EIA Kit (PerSeptive
iosystems, USA). Each value was determined from the
ean of two determinations; (5) virus titer in the serum
as determined by a plaque assay as described below.
he organ samples of each mouse were divided into two
ortions: one was immediately frozen at 280°C for titra-
ion of virus and the other was subjected to histopatho-
ogical observation or immunostaining for DEN viral an-
igens.
itration of virus
The organ samples were ground up in a mortar with
agle’s minimum essential medium supplemented with
0% Haemaccel, 10 mM HEPES (pH 7.2–7.4). The organ
uspensions were centrifuged at 15,000 rev/min for 15
in at 4°C and then the supernatants were assayed for
irus titer by the plaque method using Vero cell mono-
ayer culture under methylcellulose overlay medium. Vi-
us titer in the serum was also determined by the same
laque procedure.
ntibodies for immunostaining
Two mouse monoclonal antibodies, 504 and 301, were
mployed for detecting DEN viral antigens. Both mono-
lonal antibodies react with DEN viruses (Kimura-Kuroda
nd Yasui, 1986). Rabbit anti-hALB polyclonal antibody
Dako), which does not react with mouse albumin, was
sed as a marker for HepG2 cells. Rabbit anti-microtu-
T
Design of
Groups Transplantationa
DEN-2 virus i
Mice ageb
1 1 16 weeks
2 1 16 weeks
3 2 16 weeks
4 2 16 weeks
Note. ip, intraperitoneal; ic, intracerebral.
a Transplantation (1) or without transplantation (2).
b All mice had severe combined immunodeficiency (SCID).ule-associated protein 2 antibody, used as a marker of Beurons, was kindly provided by Dr. Murofushi of Tokyo
niversity.
istopathological examination and immunostaining
The portions of organ samples were further divided
nto two parts. One was fixed with 10% formalin and
rocessed for HE staining, and the other was cryo-
ectioned for immunostaining to search for sites of DEN
irus replication. In brief, liver or brain sections were
ncubated with DEN reactive monoclonal antibodies
mixture of 504 and 301) and anti-hALB or -MAP2 anti-
odies, respectively. After being washed, the sections
ere further incubated with biotinylated anti-mouse IgG
Amersham) and followed by Texas red-conjugated
trevptoavidin (Amersham) or fluorescein isothiocya-
ate-conjugated anti-rabbit IgG (Dako). The specimens,
ncluding lung, spleen, and small intestine, were also
tained for DEN viral antigens with the same procedure.
he stained cells were observed by confocal laser mi-
roscopy (Molecular Dynamics, Sunnyvale, CA).
tatistics
Statistical analysis was conducted using Student’s t
est. P values ,0.05 were considered significant.
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